Compare CDNA & MTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | MTX |
|---|---|---|
| Founded | 1998 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 2007 | 2004 |
| Metric | CDNA | MTX |
|---|---|---|
| Price | $66.83 | $65.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $58.83 | ★ $92.50 |
| AVG Volume (30 Days) | ★ 1.0M | 126.6K |
| Earning Date | 11-03-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | $48,324,000.00 | ★ $2,072,600,000.00 |
| Revenue This Year | $30.36 | $5.45 |
| Revenue Next Year | $6.23 | $4.81 |
| P/E Ratio | $30.04 | ★ N/A |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $13.95 | $53.94 |
| 52 Week High | $65.50 | $84.34 |
| Indicator | CDNA | MTX |
|---|---|---|
| Relative Strength Index (RSI) | 78.88 | 25.55 |
| Support Level | $17.26 | $63.65 |
| Resistance Level | N/A | $70.69 |
| Average True Range (ATR) | 2.87 | 1.40 |
| MACD | 0.90 | -0.19 |
| Stochastic Oscillator | 99.39 | 0.00 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.